➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
AstraZeneca
Harvard Business School
Baxter
Boehringer Ingelheim
Merck

Last Updated: August 3, 2021

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: NEVIRAPINE


Email this page to a colleague

« Back to Dashboard

NEVIRAPINE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Aurobindo NEVIRAPINE nevirapine SUSPENSION;ORAL 077702 ANDA Aurobindo Pharma Limited 65862-057-11 100 mL in 1 BOTTLE (65862-057-11) 2012-05-22
Aurobindo NEVIRAPINE nevirapine SUSPENSION;ORAL 077702 ANDA Aurobindo Pharma Limited 65862-057-24 240 mL in 1 BOTTLE (65862-057-24) 2012-05-22
Boehringer Ingelheim VIRAMUNE nevirapine SUSPENSION;ORAL 020933 NDA Boehringer Ingelheim Pharmaceuticals Inc. 0597-0047-24 1 BOTTLE, PLASTIC in 1 CARTON (0597-0047-24) > 240 mL in 1 BOTTLE, PLASTIC 2001-10-01
Alvogen NEVIRAPINE nevirapine TABLET, EXTENDED RELEASE;ORAL 204621 ANDA Alvogen Inc. 47781-317-30 30 TABLET in 1 BOTTLE (47781-317-30) 2015-07-14
Aurobindo Pharma Ltd NEVIRAPINE nevirapine TABLET, EXTENDED RELEASE;ORAL 208616 ANDA Aurobindo Pharma Limited 65862-932-05 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (65862-932-05) 2016-11-23
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
McKinsey
AstraZeneca
Mallinckrodt
Dow
Colorcon